| Literature DB >> 26652843 |
Celeste M Karch1, Lubov Ezerskiy2, Veronica Redaelli3, Anna Rita Giovagnoli3, Pietro Tiraboschi3, Giuseppe Pelliccioni4, Paolo Pelliccioni4, Dimos Kapetis5, Ilaria D'Amato3, Elena Piccoli3, Maria Giulia Ferretti3, Fabrizio Tagliavini3, Giacomina Rossi6.
Abstract
GRN, the gene coding for the progranulin (PGRN) protein, was recognized as a gene linked to frontotemporal lobar degeneration (FTLD). The first mutations identified were null mutations giving rise to haploinsufficiency. Missense mutations were subsequently detected, but only a small subset has been functionally investigated. We identified missense mutations (C105Y, A199V, and R298H) in FTLD cases with family history and/or with low plasma PGRN levels. The aim of this study was to determine their pathogenicity. We performed functional studies, analyzing PGRN expression, secretion, and cleavage by elastase. GRN C105Y affected both secretion and elastase cleavage, likely representing a pathogenic mutation. GRN A199V did not alter the physiological properties of PGRN and GRN R298H produced only moderate effects on PGRN secretion, indicating that their pathogenicity is uncertain. In the absence of strong segregation data and neuropathological examinations, genetic, biomarker, and functional studies can be applied to an algorithm to assess the likelihood of pathogenicity for a mutation. This information can improve our understanding of the complex mechanisms by which GRN mutations lead to FTLD.Entities:
Keywords: Frontotemporal lobar degeneration; Functional analysis; GRN; Mutation; Pathogenetic; Progranulin
Mesh:
Substances:
Year: 2015 PMID: 26652843 PMCID: PMC4738142 DOI: 10.1016/j.neurobiolaging.2015.10.029
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673